Literature DB >> 4144636

Opsonins: their function, identity, and clinical significance.

J A Winkelstein.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4144636     DOI: 10.1016/s0022-3476(73)80062-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  17 in total

1.  Pneumococcal type-associated variability in alternate complement pathway activation.

Authors:  D P Fine
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

2.  Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.

Authors:  G S Giebink; J Verhoef; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

3.  Sepsis in trauma patients.

Authors:  C C Baker; D C Hohn; D D Trunkey; F W Blaisdell
Journal:  West J Med       Date:  1979-04

4.  Opsonin system of the group B streptococcus.

Authors:  J H Mathews; P H Klesius; R A Zimmerman
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

5.  Temporal appearance of opsonizing antibody to Francisella tularensis: detection by a radiometabolic assay.

Authors:  P G Canonico; A T McManus; J A Mangiafico; L S Sammons; V G McGann; H G Dangerfield
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

6.  The role of complement and antibody in opsonization and intracellular killing of Candida albicans.

Authors:  H A Pereira; C S Hosking
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

7.  Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae.

Authors:  D S Chudwin; S G Artrip; A Korenblit; G Schiffman; S Rao
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Interactions of Pseudomonas aeruginosa with immunoglobulins and complement in sputum.

Authors:  S Hann; D S Holsclaw
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

9.  Cross-reacting opsonic antibodies to clinically important pneumococcal serotypes after pneumococcal vaccination.

Authors:  J H Braconier; E B Myhre; H Odeberg
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

10.  Complement system in pneumococcal infections.

Authors:  W P Reed; M S Davidson; R C Williams
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.